1 Introduction to Research & Analysis Reports
1.1 Blood-Brain Barrier Transport Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blood-Brain Barrier Transport Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blood-Brain Barrier Transport Drugs Overall Market Size
2.1 Global Blood-Brain Barrier Transport Drugs Market Size: 2022 VS 2029
2.2 Global Blood-Brain Barrier Transport Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Blood-Brain Barrier Transport Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Blood-Brain Barrier Transport Drugs Players in Global Market
3.2 Top Global Blood-Brain Barrier Transport Drugs Companies Ranked by Revenue
3.3 Global Blood-Brain Barrier Transport Drugs Revenue by Companies
3.4 Global Blood-Brain Barrier Transport Drugs Sales by Companies
3.5 Global Blood-Brain Barrier Transport Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Blood-Brain Barrier Transport Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Blood-Brain Barrier Transport Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Blood-Brain Barrier Transport Drugs Players in Global Market
3.8.1 List of Global Tier 1 Blood-Brain Barrier Transport Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Blood-Brain Barrier Transport Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Blood-Brain Barrier Transport Drugs Market Size Markets, 2022 & 2029
4.1.2 Carrier-mediated Transport
4.1.3 Receptor-mediated Transport
4.1.4 Absorptive-mediated Transport
4.1.5 Active Efflux Transport
4.1.6 Others
4.2 By Type – Global Blood-Brain Barrier Transport Drugs Revenue & Forecasts
4.2.1 By Type – Global Blood-Brain Barrier Transport Drugs Revenue, 2018-2023
4.2.2 By Type – Global Blood-Brain Barrier Transport Drugs Revenue, 2024-2029
4.2.3 By Type – Global Blood-Brain Barrier Transport Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Blood-Brain Barrier Transport Drugs Sales & Forecasts
4.3.1 By Type – Global Blood-Brain Barrier Transport Drugs Sales, 2018-2023
4.3.2 By Type – Global Blood-Brain Barrier Transport Drugs Sales, 2024-2029
4.3.3 By Type – Global Blood-Brain Barrier Transport Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Blood-Brain Barrier Transport Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Blood-Brain Barrier Transport Drugs Market Size, 2022 & 2029
5.1.2 Alzheimer’s Disease
5.1.3 Epilepsy
5.1.4 Parkinson’s Disease
5.1.5 Multiple Sclerosis
5.1.6 Hunter’s Syndrome
5.1.7 Brain Cancer
5.1.8 Others
5.2 By Application – Global Blood-Brain Barrier Transport Drugs Revenue & Forecasts
5.2.1 By Application – Global Blood-Brain Barrier Transport Drugs Revenue, 2018-2023
5.2.2 By Application – Global Blood-Brain Barrier Transport Drugs Revenue, 2024-2029
5.2.3 By Application – Global Blood-Brain Barrier Transport Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Blood-Brain Barrier Transport Drugs Sales & Forecasts
5.3.1 By Application – Global Blood-Brain Barrier Transport Drugs Sales, 2018-2023
5.3.2 By Application – Global Blood-Brain Barrier Transport Drugs Sales, 2024-2029
5.3.3 By Application – Global Blood-Brain Barrier Transport Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Blood-Brain Barrier Transport Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Blood-Brain Barrier Transport Drugs Market Size, 2022 & 2029
6.2 By Region – Global Blood-Brain Barrier Transport Drugs Revenue & Forecasts
6.2.1 By Region – Global Blood-Brain Barrier Transport Drugs Revenue, 2018-2023
6.2.2 By Region – Global Blood-Brain Barrier Transport Drugs Revenue, 2024-2029
6.2.3 By Region – Global Blood-Brain Barrier Transport Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Blood-Brain Barrier Transport Drugs Sales & Forecasts
6.3.1 By Region – Global Blood-Brain Barrier Transport Drugs Sales, 2018-2023
6.3.2 By Region – Global Blood-Brain Barrier Transport Drugs Sales, 2024-2029
6.3.3 By Region – Global Blood-Brain Barrier Transport Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Blood-Brain Barrier Transport Drugs Revenue, 2018-2029
6.4.2 By Country – North America Blood-Brain Barrier Transport Drugs Sales, 2018-2029
6.4.3 US Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.4.4 Canada Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.4.5 Mexico Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Blood-Brain Barrier Transport Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Blood-Brain Barrier Transport Drugs Sales, 2018-2029
6.5.3 Germany Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.5.4 France Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.5.5 U.K. Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.5.6 Italy Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.5.7 Russia Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.5.9 Benelux Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Blood-Brain Barrier Transport Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Blood-Brain Barrier Transport Drugs Sales, 2018-2029
6.6.3 China Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.6.4 Japan Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.6.5 South Korea Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.6.7 India Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Blood-Brain Barrier Transport Drugs Revenue, 2018-2029
6.7.2 By Country – South America Blood-Brain Barrier Transport Drugs Sales, 2018-2029
6.7.3 Brazil Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.7.4 Argentina Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Blood-Brain Barrier Transport Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Blood-Brain Barrier Transport Drugs Sales, 2018-2029
6.8.3 Turkey Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.8.4 Israel Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
6.8.6 UAE Blood-Brain Barrier Transport Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Cyclenium
7.1.1 Cyclenium Company Summary
7.1.2 Cyclenium Business Overview
7.1.3 Cyclenium Blood-Brain Barrier Transport Drugs Major Product Offerings
7.1.4 Cyclenium Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Cyclenium Key News & Latest Developments
7.2 BioAdvance
7.2.1 BioAdvance Company Summary
7.2.2 BioAdvance Business Overview
7.2.3 BioAdvance Blood-Brain Barrier Transport Drugs Major Product Offerings
7.2.4 BioAdvance Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2018-2023)
7.2.5 BioAdvance Key News & Latest Developments
7.3 EIP Pharma
7.3.1 EIP Pharma Company Summary
7.3.2 EIP Pharma Business Overview
7.3.3 EIP Pharma Blood-Brain Barrier Transport Drugs Major Product Offerings
7.3.4 EIP Pharma Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2018-2023)
7.3.5 EIP Pharma Key News & Latest Developments
7.4 Bioasis
7.4.1 Bioasis Company Summary
7.4.2 Bioasis Business Overview
7.4.3 Bioasis Blood-Brain Barrier Transport Drugs Major Product Offerings
7.4.4 Bioasis Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Bioasis Key News & Latest Developments
7.5 Immune Pharmaceuticals
7.5.1 Immune Pharmaceuticals Company Summary
7.5.2 Immune Pharmaceuticals Business Overview
7.5.3 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Major Product Offerings
7.5.4 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Immune Pharmaceuticals Key News & Latest Developments
7.6 AZ Therapies
7.6.1 AZ Therapies Company Summary
7.6.2 AZ Therapies Business Overview
7.6.3 AZ Therapies Blood-Brain Barrier Transport Drugs Major Product Offerings
7.6.4 AZ Therapies Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2018-2023)
7.6.5 AZ Therapies Key News & Latest Developments
7.7 Palobiofarma
7.7.1 Palobiofarma Company Summary
7.7.2 Palobiofarma Business Overview
7.7.3 Palobiofarma Blood-Brain Barrier Transport Drugs Major Product Offerings
7.7.4 Palobiofarma Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Palobiofarma Key News & Latest Developments
7.8 Bach Pharma
7.8.1 Bach Pharma Company Summary
7.8.2 Bach Pharma Business Overview
7.8.3 Bach Pharma Blood-Brain Barrier Transport Drugs Major Product Offerings
7.8.4 Bach Pharma Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Bach Pharma Key News & Latest Developments
7.9 BrainsGate
7.9.1 BrainsGate Company Summary
7.9.2 BrainsGate Business Overview
7.9.3 BrainsGate Blood-Brain Barrier Transport Drugs Major Product Offerings
7.9.4 BrainsGate Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2018-2023)
7.9.5 BrainsGate Key News & Latest Developments
7.10 CarThera
7.10.1 CarThera Company Summary
7.10.2 CarThera Business Overview
7.10.3 CarThera Blood-Brain Barrier Transport Drugs Major Product Offerings
7.10.4 CarThera Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2018-2023)
7.10.5 CarThera Key News & Latest Developments
7.11 Dainippon Sumitomo Pharma
7.11.1 Dainippon Sumitomo Pharma Company Summary
7.11.2 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Business Overview
7.11.3 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Major Product Offerings
7.11.4 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Dainippon Sumitomo Pharma Key News & Latest Developments
7.12 Fluorinov Pharma
7.12.1 Fluorinov Pharma Company Summary
7.12.2 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Business Overview
7.12.3 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Major Product Offerings
7.12.4 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Fluorinov Pharma Key News & Latest Developments
7.13 Fondazione Telethon
7.13.1 Fondazione Telethon Company Summary
7.13.2 Fondazione Telethon Blood-Brain Barrier Transport Drugs Business Overview
7.13.3 Fondazione Telethon Blood-Brain Barrier Transport Drugs Major Product Offerings
7.13.4 Fondazione Telethon Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Fondazione Telethon Key News & Latest Developments
7.14 Minoryx
7.14.1 Minoryx Company Summary
7.14.2 Minoryx Business Overview
7.14.3 Minoryx Blood-Brain Barrier Transport Drugs Major Product Offerings
7.14.4 Minoryx Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Minoryx Key News & Latest Developments
7.15 NewGen Therapeutics
7.15.1 NewGen Therapeutics Company Summary
7.15.2 NewGen Therapeutics Business Overview
7.15.3 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Major Product Offerings
7.15.4 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2018-2023)
7.15.5 NewGen Therapeutics Key News & Latest Developments
8 Global Blood-Brain Barrier Transport Drugs Production Capacity, Analysis
8.1 Global Blood-Brain Barrier Transport Drugs Production Capacity, 2018-2029
8.2 Blood-Brain Barrier Transport Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Blood-Brain Barrier Transport Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Blood-Brain Barrier Transport Drugs Supply Chain Analysis
10.1 Blood-Brain Barrier Transport Drugs Industry Value Chain
10.2 Blood-Brain Barrier Transport Drugs Upstream Market
10.3 Blood-Brain Barrier Transport Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Blood-Brain Barrier Transport Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の血液脳関門輸送薬市場予測2023-2029：キャリア媒介輸送、受容体媒介輸送、吸収媒介輸送、能動排出輸送、その他 |
| 【英語タイトル】Blood-Brain Barrier Transport Drugs Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5726 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：113 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の血液脳関門輸送薬市場規模と予測を収録しています。・世界の血液脳関門輸送薬市場：売上、2018年-2023年、2024年-2029年 ・世界の血液脳関門輸送薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の血液脳関門輸送薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「キャリア媒介輸送」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 血液脳関門輸送薬のグローバル主要企業は、Cyclenium、 BioAdvance、 EIP Pharma、 Bioasis、 Immune Pharmaceuticals、 AZ Therapies、 Palobiofarma、 Bach Pharma、 BrainsGate、 CarThera、 Dainippon Sumitomo Pharma、 Fluorinov Pharma、 Fondazione Telethon、 Minoryx、 NewGen Therapeuticsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、血液脳関門輸送薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の血液脳関門輸送薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の血液脳関門輸送薬市場：タイプ別市場シェア、2022年 ・キャリア媒介輸送、受容体媒介輸送、吸収媒介輸送、能動排出輸送、その他 世界の血液脳関門輸送薬市場：用途別、2018年-2023年、2024年-2029年 世界の血液脳関門輸送薬市場：用途別市場シェア、2022年 ・アルツハイマー病、てんかん、パーキンソン病、多発性硬化症、ハンター症候群、脳腫瘍、その他 世界の血液脳関門輸送薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の血液脳関門輸送薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における血液脳関門輸送薬のグローバル売上、2018年-2023年 ・主要企業における血液脳関門輸送薬のグローバル売上シェア、2022年 ・主要企業における血液脳関門輸送薬のグローバル販売量、2018年-2023年 ・主要企業における血液脳関門輸送薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Cyclenium、 BioAdvance、 EIP Pharma、 Bioasis、 Immune Pharmaceuticals、 AZ Therapies、 Palobiofarma、 Bach Pharma、 BrainsGate、 CarThera、 Dainippon Sumitomo Pharma、 Fluorinov Pharma、 Fondazione Telethon、 Minoryx、 NewGen Therapeutics ************************************************************* ・調査・分析レポートの概要 血液脳関門輸送薬市場の定義 市場セグメント 世界の血液脳関門輸送薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の血液脳関門輸送薬市場規模 世界の血液脳関門輸送薬市場規模：2022年 VS 2029年 世界の血液脳関門輸送薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの血液脳関門輸送薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の血液脳関門輸送薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：キャリア媒介輸送、受容体媒介輸送、吸収媒介輸送、能動排出輸送、その他 血液脳関門輸送薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：アルツハイマー病、てんかん、パーキンソン病、多発性硬化症、ハンター症候群、脳腫瘍、その他 血液脳関門輸送薬の用途別グローバル売上・予測 ・地域別市場分析 地域別血液脳関門輸送薬市場規模 2022年と2029年 地域別血液脳関門輸送薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Cyclenium、 BioAdvance、 EIP Pharma、 Bioasis、 Immune Pharmaceuticals、 AZ Therapies、 Palobiofarma、 Bach Pharma、 BrainsGate、 CarThera、 Dainippon Sumitomo Pharma、 Fluorinov Pharma、 Fondazione Telethon、 Minoryx、 NewGen Therapeutics ... |
This report aims to provide a comprehensive presentation of the global market for Blood-Brain Barrier Transport Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood-Brain Barrier Transport Drugs. This report contains market size and forecasts of Blood-Brain Barrier Transport Drugs in global, including the following market information:
Global Blood-Brain Barrier Transport Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Blood-Brain Barrier Transport Drugs Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Blood-Brain Barrier Transport Drugs companies in 2022 (%)
The global Blood-Brain Barrier Transport Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Carrier-mediated Transport Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Blood-Brain Barrier Transport Drugs include Cyclenium, BioAdvance, EIP Pharma, Bioasis, Immune Pharmaceuticals, AZ Therapies, Palobiofarma, Bach Pharma and BrainsGate, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Blood-Brain Barrier Transport Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blood-Brain Barrier Transport Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Blood-Brain Barrier Transport Drugs Market Segment Percentages, by Type, 2022 (%)
Carrier-mediated Transport
Receptor-mediated Transport
Absorptive-mediated Transport
Active Efflux Transport
Others
Global Blood-Brain Barrier Transport Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Blood-Brain Barrier Transport Drugs Market Segment Percentages, by Application, 2022 (%)
Alzheimer’s Disease
Epilepsy
Parkinson’s Disease
Multiple Sclerosis
Hunter’s Syndrome
Brain Cancer
Others
Global Blood-Brain Barrier Transport Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Blood-Brain Barrier Transport Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blood-Brain Barrier Transport Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Blood-Brain Barrier Transport Drugs revenues share in global market, 2022 (%)
Key companies Blood-Brain Barrier Transport Drugs sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Blood-Brain Barrier Transport Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cyclenium
BioAdvance
EIP Pharma
Bioasis
Immune Pharmaceuticals
AZ Therapies
Palobiofarma
Bach Pharma
BrainsGate
CarThera
Dainippon Sumitomo Pharma
Fluorinov Pharma
Fondazione Telethon
Minoryx
NewGen Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Blood-Brain Barrier Transport Drugs, market overview.
Chapter 2: Global Blood-Brain Barrier Transport Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Blood-Brain Barrier Transport Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Blood-Brain Barrier Transport Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Blood-Brain Barrier Transport Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の血液脳関門輸送薬市場予測2023-2029：キャリア媒介輸送、受容体媒介輸送、吸収媒介輸送、能動排出輸送、その他] (コード：MMG23JU5726)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の血液脳関門輸送薬市場予測2023-2029：キャリア媒介輸送、受容体媒介輸送、吸収媒介輸送、能動排出輸送、その他]についてメールでお問い合わせ |
